|
|
|
 |
 |
 |
 |
 |
|
Curriculum Vitae
Alexander M. Reyzelman, D.P.M., F.A.C.F.A.S. California School of Podiatric Medicine 2299 Post St. Ste. 205 San Francisco, California 94115 (415) 292-0638 (415) 292-0718 fax Email: areyzelman@samuelmerritt.edu
Education:
1991-1995 California College of Podiatric Medicine San Francisco, CA Doctor of Podiatric Medicine
1987-1991 University of San Francisco San Francisco, CA Bachelor of Science in Biology
Postgraduate Training:
1995 – 1996 Primary Podiatric Medical Residency 1996 - 1998 Podiatric Surgical Residency Univeristy of Texas Health Science Center at San Antonio 2004 Intensive one week course in peripheral nerve surgery
Work Experience:
1998 to present Private practice, San Francisco, CA, Castro Valley, CA 1999 to 2001 Clinical Director, Pacific Coast Wound Care, San Francisco, CA 2000 to 2001 Co-chair Department of Medicine, California College of Podiatric Medicine, San Francisco, CA 9/2001-2009 Assistant Professor, Chairman, Department of Medicine, California School of Podiatric Medicine at Samuel Merritt College 7/2009- present Associate Professor, Chairman, Dept of Medicine, California School of Podiatric Medicine at Samuel Merritt University.
Hospital Staff Appointments:
1999 to present California Pacific Medical Center San Francisco, CA
1999 to present Eden Hospital Castro Valley, CA
2008 to present St. Mary’s Hospital San Francisco, CA
2008 to present St. Rose Hospital Hayward, CA
1998 to 2000 Pacific Coast Hospital San Francisco, CA
1999 to 2007 Mercy San Juan Hospital Carmichael, CA
1998 to 2001 Mount Zion HospitalSan Francisco, CA
1995 to 1998 University Hospital (Residency) San Antonio, Tx
1995 to 1998 Audie L. Murphy Veterans Administration Hospital (Residency) San Antonio, Tx
Licensure:
1996-98 Texas 1998 to present California 2005 to present Nevada
Certification: 2005 to present Board Certified in Foot Surgery
1995 to 1999 Advanced Cardiac Life Support
1995 to Present Basic Life Support
1998 to Present QME, AME
Professional Affiliations:
1995 to Present American Podiatric Medical Association
1998 to Present California Podiatric Medical Association
1995 –1998 Texas Podiatric Medical Association
1995 to Present American College of Foot and Ankle Surgeons
1995 to Present American Diabetes Association
Lectures and Workshops:
1995-1996 -Peripheral nerve injuries. UTHSC-SA -Tendon injury and surgery. UTHSC-SA -Radiographic analysis of a bunion UTHSC-SA 1996-1997 -Differential diagnosis of lower extremity edema. Bandera Hill Country Seminar, Bandera, Texas. -Diabetic footwear post amputation. Vascular surgery grand rounds -Implant arthroplasty of the great toe joint. UTHSC-SA -Klippel Trenuanay Syndrome. Podiatry grand rounds. 1997-1998 -Foot burns in patients with diabetes. Podiatry grand rounds -Isolated subtalar arthrodesis vs. triple arthrodesis. UTHSC-SA -Instructional course on interpretation of non-invasive vascular arterial studies and lower extremity angiograms. Post-graduate Diabetic Foot Course. -Instructional hands-on course on foot amputations. Post-graduate Diabetic Foot Course. -Interpretation of non-invasive arterial study as it relates to healing potential. Bandera Hill Country Seminar, Bandera, Texas. -Immaging modalities of the diabetic foot. NPMA Conference, San Antonio, Texas. -Footwear and insoles for diabetic patient workshop. Centers of Wound Healing Excellence: Improving Outcomes with New Technologies, UTHSC-SA 1999 -Surgical indications for Charcot’s arthropathy, Limb salvage in diabetic patients, Clinical application of non-invasive arterial studies. Mid-Atlantic Podiatric Medical Association, West Virginia 2000 -Diabetic workshop, Super Seminar 2000, Las Vegas Nevada. -Complicated wound panel, Western Podiatric Medical Congress, Anaheim, CA. -Wound Care, The Multidisciplinary Approach. Essential of Practice Seminar, San Francisco, CA. 2001 -Diabetic workshop. Super Seminar 2001 Las Vegas Nevada -Moderator for the Wound Care Track at the Super Seminar, Las Vegas Nevada -Wound Bed Preparation. San Francisco, CA -Advances in Wound Care Technologies. Noon Conference Eden Hospital, Castro Valley CA. -Diabetic Foot. Medicine Grand Rounds, California Pacific Medical Center, San Francisco CA. -Bioengineered Skin Equivalents. Alameda County Podiatric Medical Association, San Leandro CA -Validation of Multidisciplinary Approach. Western Podiatric Medical Congress, Anaheim CA. -Differential Diagnosis and Assessment of Lower Extremity ulcerations. Sutter Visiting Nurses, Vallejo CA -Wound Bed Preparation. WOCN Association, Sacramento CA 2002 -Bioengineered Skin Equivalents: Dermagraft, SuperSeminar 2002, Las Vegas, NV -Lower Extremity Vascular Evaluation in a Diabetic Patient. Super Seminar 2002, Las Vegas, NV -Diabetic/Wound Care Workshop, Super Seminar 2002, Las Vegas, NV -Vacular Compromised Digit, Essentials of Practice 2002 -Pathogenesis of Diabetic Foot Ulcerations, University of Texas Diabetic Foot Conference, San Antonio, TX 2002. -Diabetic Foot Infections, San Francisco and San Mateo County Podiatry Association, 2002 -Diabetic Foot Infections, Santa Clara County Podiatry Association, 2002
2003 -Diabetic Foot Infections, Alameda and Contra Costa County Podiatry Association, 2003 -Approach to lower extremity ulcerations, Sutter Visiting Nurses Association, 2003 -Diabetic Wound Care workshop, Super Seminar 2003, Las Vegas, NV -Advances in Wound Care. The Role of the VAC., The Western Seminar 2003, Anaheim, CA -Management of the Diabetic Foot Ulcerations, Modesto and Stockton Podiatry Association, Stockton, CA 2003. -Diabetic Foot Infections, Sacramento Podiatry Association, Sacramento, CA 2003
2004 -Diabetic Wound Care Track, Super Seminar 2004 -The Role of the VAC, The Western 2004, Anaheim, CA -Diabetic Wound Care Update, Alameda Contra Costa Podiatry Association, CA
2005 -Transmetatarsal Amputations, The Western 2005, Anaheim, CA -Patient Care and Research, The Western 2005, Anaheim, CA -Peripheral Neuropathy and Its Effects on the Lower Extremity. UCSF, SF, CA. -Update on the use of Antibiotics in Treatment of Diabetic Foot Infections, San Francisco, CA
2007 -Management of Diabetic Foot Infections. St. Mary’s Hospital Department of Podiatry. April 2007. -Management of the Diabetic Foot. California Pacific Medical Center, Grand Rounds, June 2007 -Treatment of Diabetic Foot Infections. Las Vegas Nevada August 2007. -Treatment of Diabetic Foot Infections. University Medical Center Grand Rounds, Las Vegas Nevada, November 2007 -Management of Diabetic Foot Infections. UCSF Surgery Dept. July 2007 -Systemic Approach to Diabetic Foot Infections, Diabetic Foot Update Conference, University of Texas Health Science Center at San Antonio, December 2007 -Teaching Points in Performing Foot Amputations, Diabetic Foot Update Conference, University of Texas Health Science Center at San Antonio, December 2007
2008 -Common Foot Problems in the Emergency Department, Eden Hospital Emergency Department. -Pathophysiology of the Diabetic Foot Ulcerations. Pacific Coast Region of the WOCN, Sacramento, CA.
2009 Using Skin Expansion Device in Lower Extremity Wounds, 1st Annual Wound Care Conference, Oakland, CA
Leadership: 2009-present Associate Professor, Chair Department of Medicine, California School of Podiatric Medicine at Samuel Merritt University 2001-present Assistant Professor, Chair Department of Medicine, California School of Podiatric Medicine 2000 – 2001 Co-chair, Department of Medicine, California College of Podiatric Medicine, San Francisco, CA 2003- present Board of Editorial Advisors for Podiatry Today 2000 – 2003 Editor of Diabetes Watch column Podiatry Today journal. 1997 – 1998 Administrative and academic chief resident Department of Orthopaedics/Podiatry Service University of Texas Health Science Center at San Antonio 1994-1995 President of Health and Honors Fraternity at the University of San Francisco
Research/ Completed Clinical Trials Primary Investigator for: An Open Label, Multicenter Study to Evaluate The Use of Dermagraft in Patients with Diabetic Foot Ulcers. (IDE), Advanced Tissue Sciences. Completed -12/2001.
Primary Investigator for: A Phase III, Prospective, Randomized, Comparative Study of Drug XXX to placebo in subjects with acute pain following bunionectomy surgery. Completed- 10/2000.
Primary Investigator for: “A Phase III, Prospective, Randomized, Stratified, Comparative Study of Next Generation Cover Dressing Versus Two Competitive Foam Dressings in the Management of Venous Leg Ulcers” Convatec. Completed-6/29/02.
Primary Investigator for: “A Phase IV Study of Aquacel Ag Dressing Versus Saline-Moistened Gauze in the Management of Diabetic Foot Ulcers” Completed 2004
Primary Investigator for: “A Comparative Prospective, Randomized Double-Masked, Parallel Group, Controlled Trial of Celleration Mist Therapy System (MTS) Versus Sham Control When Added to Standard of Care in the Treatment of Diabetic Neuropathic Ulcers”, Completed 2004
A Prospective, Randomized, Controlled, Multi-center Pivotal Trial of AutoloGel™ Versus Control When Added to the Standard of Care in the Treatment of Non-healing Diabetic Foot Ulcer, Completed 2005.’
Primary Investigator for: “A Clinical Trial to Assess the Efficacy and Safety of Cefdinir for the Treatment of Uncomplicated Skin and Skin Structure Infections in The Diabetic Foot.” Completed 2005.
Primary Investigator for: “A Randomized Controlled Multicenter Trial of Vacuum Assisted Closure Therapy in the Treatment and Blinded Evaluation of Venous Stasis Ulcers”
Primary Investigator for: “A Trial Comparing topical antifungal agents in the treatment of tinea pedis.
Primary Investigator for “A Confirmatory Study to Evaluate The Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (Orcel) For the Treatment of Venous Ulcers”
Primary Investigator for: “A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram-Positive Skin and Skin Structure Infections with a Focus on Patients with Infections Due to Methicillin-Resistant Staphylococcus Aureus.
Primary Investigator for: “Linezolid in the Treatment of Subjects with Complicated Skin and Soft Tissue Infections Proven To Be Due to Methicillin-Resistant Staphylococcus Aureus”
A Prospective Randomized Trial in the Treatment of Subjects with Onychomycosis.
Primary Investigator for “A Multi-Center, Double-Blind, Randomized Study Assessing the Efficacy of a drug for Diabetic Peripheral Neuropathy.
KCI VAC Protocol VAC2001-08, “A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy in the Treatment and Blinded Evaluation of Diabetic Foot Ulcer”.
Primary Investigator for “A Multi-Center, comparator trial, comparing two different compression bandage systems for venous leg ulcers”. 3M Corporation
A Randomized, Blinded-Assessor, Controlled Study of NVC-101 in the Treatment of Chronic Non-Healing Venous Stasis Ulcers.
A Multicenter, randomized study of the safety and preliminary efficacy of topical low-dose nicotine gell (XXX) in patients with plantar diabetic foot ulcers
Primary Investigator for “A Multi-Center, Double-Blind, Randomized, Parallel, Vehicle-Controlled Dose-Ranging Study Assessing the Safety and Efficacy of (XXX) Gel Versus Matching Vehicle Gel When Applied Topically for Three Months to Subjects with Diabetic, Neuropathic, Foot Ulcers”
“Pivotal Study to Evaluate the Efficacy and Safety of Dermal-Living Skin Replacement (XXX) in the Treatment of Chronic Diabetic Foot Ulcers XXX-2004”.
A Prospective, Randomized, Comparative Parallel Study of Acellular Matrix Wound Dressing In the Management of Diabetic Foot Ulcers
A Prospective, Multi-Centre, Double Blind Randomized Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of (XXX) in a Phase III Trial with Four-Layer Therapeutic Compression, For the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency”
A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of Healadex Wound Dressing in the Treatment of Chronic Ulcers of the Lower Extremities, Protocol #XXX
A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multi-Center Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Gel 0.77% to Loprox® Gel (Ciclopirox) 0.77% in the Treatment of Interdigital Tinea Pedis,
A Multicenter, randomized, double-blind, comparison study of the safety and efficacy of a once-daily dose of tigecycline versus Ertapenem for the treatment of foot infections in subjects with diabetes.
A Randomized, Controlled, Open-Label Study to Investigate the Safety and Efficacy of a Topical XXX (XXX) in Combination with Antimicrobial Therapy Compared to Antimicrobial Therapy Alone in Diabetic Patients with Moderately Infected Lower Extremity Skin Ulcers”.
Clinical Trials In Progress
“A Prospective, Randomized, Controlled, Unmasked, Multiple Treatment, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of an Interactive Wound Dressing containing (XXX) versus Conventional Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Cross-Sectional Study: Comparing Pressure Specified Sensory Device vs. Electrodiagnostic Studies in diagnosing Tarsal Tunnel Syndrome.
Prospective study comparing injection technique in patients with plantar fasciitis. Medial vs. Plantar approach.
Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction with Standard of Care in the Treatment of Diabetic Foot Ulcers”
Evaluation of a Medical Food for Chronic Wounds of the Lower Extremity in Patients with Diabetes. Multicenter trial. A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of (XXX) in Venous Leg Ulcers
Consulting: Medicis Laboratories, Podiatry Advisory Panel, 2002
Eli Lilly, Neuropathy Advisory Panel, 2004
Wound Care Technologies Inc., 2008- present
Aalnex Inc. 2008- present
Publications:
Day, R.D., Reyzelman, A., Harkless, L.B., Evaluation and Management of the Interdigital Corn: A Literature Review. Clin Pod Med Surg 13:2, April, 1996.
Reyzelman, A.M., Van Gils, C, Hardin, T.C., Vayser, D.J., Harkless, L.B.,Vancomycin-resistant Enterococci (VRE) Osteomyelitis in the Foot: A Case Report. J. Am. Pod. Med. Assoc. 87:9, September 1997.
Felder-Johnson, K.L., Reyzelman, A.M. “Foot and Ankle Trauma”, Foot and Ankle Secrets, 1st Ed. Hanley & Belfus, Philadelphia , PA 1998.
Reyzelman, A.M., Lomba, M.R., Vayser, D.J., Day, R.D., Burnett, O.E., Central Pain Syndrome with Manifestations in the Foot: A Case Report and Literature Review. J. Amer. Pod. Med. Assoc. 88:5, May 1998.
Reyzelman, A.M., Armstrong, D.G., Hadi, S.A., Vayser, D.J., Husain, S.K., Harkless, L.B., Emergence of Non-Group A Streptococcal Necrotizing Diabetic Foot Infections. J. Amer. Pod. Med. Assoc. 88:6, June 1998.
Morgan, C.B., Reyzelman, A.M., Cai, T.H., Harkless, L.B., Pre-operative Assessment of Transplant Patient: J Foot & Ankle Surgery. 37:4, July/August 1998.
Reyzelman, A.M., Hadi, S.; Armstrong, D.G., Limb Salvage with Chopart’s Amputation and Tendon Balancing: J. Amer. Pod. Med. Assoc. 89:2, February 1999.
Reyzelman, A.M., Lipsky, BA., Hadi, S., Harkless, L.B., Armstrong DG. The Increased Prevalence of Severe Necrotizing Infections Caused by Non-Group A Streptococci. J. Amer. Pod. Med. Assoc. 89:9, September 1999
Steinberg, J.S., Reyzelman, A.M.: The Diabetic Foot:A Multidisciplinary Team Approach. Podiatry Today 1999
Reyzelman, A.R., Tuthill, J.: Management of Diabetic Wounds and Infections, Home Health Care Consultant, 7:4 April 2000.
Reyzelman, A.R., Loveland, L.J., Melillo, T.C.: Tendon Rebalancing Improves Chopart Outcomes. Biomechanics, May 2000.
Loveland, L.J., Reyzelman, A.M.: Why Tendon Balancing is Essential For Amputation of The High-Risk Diabetic Foot. Podiatry Today, May 2000
Reyzelman, A.M., Trombello, K.A., Vayser, D.J., Armstrong, D.G., Harkless, L. B.: Are Antibiotics Necessary in the Treatment of Locally Infected Ingrown Toenails? Arch. Fam. Med. 9:Sept/Oct. 2000.
Jansma, J., Van Voris, K., Reyzelman, A.M: Management of Diabetic Wounds and Infections in the Elderly Patient. Clinical Geriatrics. 9:7, June 2001
La Fontaine, J., Reyzelman A.M., Rothenberg, G., Husain, K., Harkless, L.B.: The Role of Revascularization in Transmetatarsal Amputations: J. Am. Pod. Assoc. 91:10, November/December 2001
Reyzelman, A., Tidwell, A.: Expert’s Tips on Wound Bed Preparation: Podiatry Today July 2003.
Reyzelman, A.: Bracing and Orthotics. Guest Editor. Foot and Ankle Quarterly The Seminar Journal. Vol 16:4 Winter 2004.
Reyzelman, A.: Current Trends in Performing Matrixectomies Podiatry Today, December 2005.
Reyzelman, A., Fiorito, J., Hoover, C., Brewer, M.: Key Insights on Lower Extremity Nerve Testing, Podiatry Today, October 2007
Moffatt, C.J., Edwards, M.C., Treadwell, T., Miller, M., Shafer, L., Sibbald, G., Brassard, A., McIntosh, A., Reyzelman, A., Price, P., Merkel, K., Walters, S., Harding, K.A. A randomized controlled 8 week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers., Int Wound J 2008;5:267-279.
Reyzelman AR, Crews RT, Moore JC, Moore L, Mukker JS, Offutt S, Tallis A, Turner WB, Vayser D, Winters C, Armstrong DG, “Clinical Effectiveness of an Acellular Dermal Regenerative Tissue Matrix Compared to Standard Wound Management in Healing Diabetic Foot Ulcers: A Prospective, Randomized, Multi-Center Study, Int Wound Journal, 2009, In Press
Poster Presentations: Clinical Effectiveness of an Acellular Dermal Regenerative Tissue Matrix Compared to Standard Wound Management in Healing Diabetic Foot Ulcers: A Prospective, Randomized, Multi-Center Study. Presented at DFCON, Los Angeles, CA 3/2009.
Continuous External Tissue Expander For Closure of Lower Extremity Wounds. A Case Series. Presented at DFCON, Los Angeles, CA, 3/2009 |
|
||||||||||||
 |
|
 |
|||
| © Copyright 2005 Bay Area Footcare. All rights reserved. | |||||
|
|||||
